These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26096788)

  • 1. Quantitative muscle MRI: A powerful surrogate outcome measure in Duchenne muscular dystrophy.
    Bonati U; Hafner P; Schädelin S; Schmid M; Naduvilekoot Devasia A; Schroeder J; Zuesli S; Pohlman U; Neuhaus C; Klein A; Sinnreich M; Haas T; Gloor M; Bieri O; Fischmann A; Fischer D
    Neuromuscul Disord; 2015 Sep; 25(9):679-85. PubMed ID: 26096788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 6-minute walk test, motor function measure and quantitative thigh muscle MRI in Becker muscular dystrophy: A cross-sectional study.
    Fischer D; Hafner P; Rubino D; Schmid M; Neuhaus C; Jung H; Bieri O; Haas T; Gloor M; Fischmann A; Bonati U
    Neuromuscul Disord; 2016 Jul; 26(7):414-22. PubMed ID: 27209345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial.
    Hafner P; Bonati U; Rubino D; Gocheva V; Zumbrunn T; Gueven N; Fischer D
    Trials; 2016 Aug; 17(1):389. PubMed ID: 27488051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal 2-point dixon muscle magnetic resonance imaging in becker muscular dystrophy.
    Bonati U; Schmid M; Hafner P; Haas T; Bieri O; Gloor M; Fischmann A; Fischer D
    Muscle Nerve; 2015 Jun; 51(6):918-21. PubMed ID: 25736228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI Assessment of Motor Capabilities in Patients with Duchenne Muscular Dystrophy According to the Motor Function Measure Scale.
    Suslov V; Suslova G; Lytaev S
    Tomography; 2022 Apr; 8(2):948-960. PubMed ID: 35448710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal reliability of outcome measures in patients with Duchenne muscular dystrophy.
    Nagy S; Schädelin S; Hafner P; Bonati U; Scherrer D; Ebi S; Schmidt S; Orsini AL; Bieri O; Fischer D
    Muscle Nerve; 2020 Jan; 61(1):63-68. PubMed ID: 31469921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroids in Duchenne muscular dystrophy: impact on the motor function measure sensitivity to change and implications for clinical trials.
    Schreiber A; Brochard S; Rippert P; Fontaine-Carbonnel S; Payan C; Poirot I; Hamroun D; Vuillerot C;
    Dev Med Child Neurol; 2018 Feb; 60(2):185-191. PubMed ID: 28990163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal study of multi-parameter quantitative magnetic resonance imaging in Duchenne muscular dystrophy: hyperresponsiveness of gluteus maximus and detection of subclinical disease progression in functionally stable patients.
    Peng F; Xu H; Song Y; Xu K; Li S; Cai X; Guo Y; Gong L
    J Neurol; 2023 Mar; 270(3):1439-1451. PubMed ID: 36385201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study.
    Wren TA; Bluml S; Tseng-Ong L; Gilsanz V
    AJR Am J Roentgenol; 2008 Jan; 190(1):W8-12. PubMed ID: 18094282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timed function tests, motor function measure, and quantitative thigh muscle MRI in ambulant children with Duchenne muscular dystrophy: A cross-sectional analysis.
    Schmidt S; Hafner P; Klein A; Rubino-Nacht D; Gocheva V; Schroeder J; Naduvilekoot Devasia A; Zuesli S; Bernert G; Laugel V; Bloetzer C; Steinlin M; Capone A; Gloor M; Tobler P; Haas T; Bieri O; Zumbrunn T; Fischer D; Bonati U
    Neuromuscul Disord; 2018 Jan; 28(1):16-23. PubMed ID: 29174526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy.
    Fischmann A; Hafner P; Gloor M; Schmid M; Klein A; Pohlman U; Waltz T; Gonzalez R; Haas T; Bieri O; Fischer D
    J Neurol; 2013 Apr; 260(4):969-74. PubMed ID: 23138982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Skeletal Muscle MRI: Part 1, Derived T2 Fat Map in Differentiation Between Boys With Duchenne Muscular Dystrophy and Healthy Boys.
    Johnston JH; Kim HK; Merrow AC; Laor T; Serai S; Horn PS; Kim DH; Wong BL
    AJR Am J Roentgenol; 2015 Aug; 205(2):W207-15. PubMed ID: 26204309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory Duchenne muscular dystrophy children: cross-sectional correlation between function, quantitative muscle ultrasound and MRI.
    Abdulhady H; Sakr HM; Elsayed NS; El-Sobky TA; Fahmy N; Saadawy AM; Elsedfy H
    Acta Myol; 2022 Mar; 41(1):1-14. PubMed ID: 35465338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Elbow Flexor MRI Fat Fraction With Loss of Hand-to-Mouth Movement in Patients With Duchenne Muscular Dystrophy.
    Naarding KJ; van der Holst M; van Zwet EW; van de Velde NM; de Groot IJM; Verschuuren JJGM; Kan HE; Niks EH
    Neurology; 2021 Oct; 97(17):e1737-e1742. PubMed ID: 34493619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responsiveness of the motor function measure in patients with spinal muscular atrophy.
    Vuillerot C; Payan C; Iwaz J; Ecochard R; Bérard C;
    Arch Phys Med Rehabil; 2013 Aug; 94(8):1555-61. PubMed ID: 23380348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Skeletal Muscle MRI: Part 2, MR Spectroscopy and T2 Relaxation Time Mapping-Comparison Between Boys With Duchenne Muscular Dystrophy and Healthy Boys.
    Kim HK; Serai S; Lindquist D; Merrow AC; Horn PS; Kim DH; Wong BL
    AJR Am J Roentgenol; 2015 Aug; 205(2):W216-23. PubMed ID: 26204310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle Quantitative MR Imaging and Clustering Analysis in Patients with Facioscapulohumeral Muscular Dystrophy Type 1.
    Lareau-Trudel E; Le Troter A; Ghattas B; Pouget J; Attarian S; Bendahan D; Salort-Campana E
    PLoS One; 2015; 10(7):e0132717. PubMed ID: 26181385
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Gerhalter T; Gast LV; Marty B; Martin J; Trollmann R; Schüssler S; Roemer F; Laun FB; Uder M; Schröder R; Carlier PG; Nagel AM
    J Magn Reson Imaging; 2019 Oct; 50(4):1103-1113. PubMed ID: 30719784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative NMRI and NMRS identify augmented disease progression after loss of ambulation in forearms of boys with Duchenne muscular dystrophy.
    Wary C; Azzabou N; Giraudeau C; Le Louër J; Montus M; Voit T; Servais L; Carlier P
    NMR Biomed; 2015 Sep; 28(9):1150-62. PubMed ID: 26215733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials.
    Ricotti V; Evans MR; Sinclair CD; Butler JW; Ridout DA; Hogrel JY; Emira A; Morrow JM; Reilly MM; Hanna MG; Janiczek RL; Matthews PM; Yousry TA; Muntoni F; Thornton JS
    PLoS One; 2016; 11(9):e0162542. PubMed ID: 27649492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.